Kenshi Hayashi et al. JACEP 2016;2:

Slides:

Advertisements

Similar presentations

Oana Dickinson et al. JACEP 2016;2:

Advertisements

Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:

Takekuni Hayashi et al. JACEP 2016;2:27-35

Marwan Badri et al. JACEP 2015;1:

Takekuni Hayashi et al. JACEP 2016;2:27-35

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Waddah Maskoun et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:

Pablo Ávila et al. JACEP 2015;1:

Daniel Frenkel et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:89-96

Ashish Shukla et al. JACEP 2015;1:41-51

Julien Seitz et al. JACEP 2016;2:

Belinda Gray et al. JCHF 2013;1:

Adam B. Greenbaum et al. JACEP 2015;1:

David F. Katz et al. JACEP 2016;j.jacep

Simon W. Rabkin et al. JACEP 2017;j.jacep

Pablo B. Nery et al. JACEP 2016;2:

Muhammad Shahreyar et al. JACEP 2016;j.jacep

Patrick M. Boyle et al. JACEP 2018;4:

Junjie Zhang et al. JACEP 2017;3:

Ammar M. Killu et al. JACEP 2016;j.jacep

Junjie Zhang et al. JACEP 2017;j.jacep

Jong Sung Park et al. JACEP 2016;2:

Stavros Stavrakis et al. JACEP 2015;1:1-13

Prakash Harikrishnan et al. JACEP 2015;1:

Peter F. Aziz et al. JACEP 2015;1:62-70

Mohit K. Turagam et al. JACEP 2017;3:

Moussa Mansour et al. JACEP 2017;3:

Mu Qin et al. JACEP 2017;j.jacep

Adam B. Greenbaum et al. JACEP 2015;1:

Mintu P. Turakhia et al. JACEP 2016;2:

Leonard M. Rademakers et al. JACEP 2016;2:

Prakash Harikrishnan et al. JACEP 2015;1:

Pouria Alipour et al. JACEP 2017;j.jacep

K.R. Julian Chun et al. JACEP 2017;3:

S.M. Afzal Sohaib et al. JACEP 2015;1:

Vivek Y. Reddy et al. JACEP 2016;2:

Prabhat Kumar et al. JACEP 2016;j.jacep

Yoshitaka Kimura et al. JACEP 2016;2:

Emilce Trucco et al. JACEP 2018;j.jacep

Marwan Badri et al. JACEP 2015;1:

Vittorio Calzolari et al. JACEP 2017;3:

Kenshi Hayashi et al. JACEP 2016;2:

David F. Katz et al. JACEP 2017;3:20-28

Jennifer T. Thibodeau et al. JCHF 2014;2:24-31

P. Michael Grossman et al. JCIN 2009;2:

Moussa Mansour et al. JACEP 2016;j.jacep

Stuart A. Ostby et al. JACEP 2016;2:

Alexander Sedaghat et al. JACEP 2016;j.jacep

Ayman A. Hussein et al. JACEP 2017;3:1-9

Mintu P. Turakhia et al. JACEP 2016;2:

Simon W. Rabkin et al. JACEP 2017;3:

Simon W. Rabkin et al. JACEP 2017;3:

Emilce Trucco et al. JACEP 2018;j.jacep

K.R. Julian Chun et al. JACEP 2017;3:

S.M. Afzal Sohaib et al. JACEP 2015;1:

Fred Kusumoto JACEP 2017;j.jacep

Aya Miyazaki et al. JACEP 2016;2:

Björn Redfors et al. JACEP 2017;j.jacep

Matthew M. Zipse et al. JACEP 2015;1:94-102

Adam B. Greenbaum et al. JACEP 2015;1:

Daniele Muser et al. JACEP 2017;j.jacep

Miyako Igarashi et al. JACEP 2018;4:

Duy T. Nguyen et al. JACEP 2017;3:

Saadia Sherazi et al. JACEP 2015;1:74-80

Ryan R. Reeves et al. JCIN 2015;8:

Anneline S.J.M. te Riele et al. JACEP 2015;1:

Distribution of QTc values for patients with and without long QT syndrome (LQTS). Distribution of QTc values for patients with and without long QT syndrome.

Presentation transcript:

Kenshi Hayashi et al. JACEP 2016;2:279-287 Distribution of Study Patients and the Frequency of LQTS Mutation Carriers by the 1993, 2006, and 2011 Criteria The application of the 2011 criteria significantly increased the number of patients identified with a high probability of long QT syndrome (LQTS). The probability of carrying mutations in patients with a high probability of LQTS was comparable among the 3 criteria. *p = 0.0002 or †p = 0.0014 versus high probability using the 2011 criteria; ‡p = 0.0014 or §p = 0.0013 versus mutation carriers with intermediate probability using the 2011 criteria. High = high probability of having LQTS; Intermediate = intermediate probability of having LQTS; Low = low probability of having LQTS. Kenshi Hayashi et al. JACEP 2016;2:279-287 American College of Cardiology Foundation